Loading clinical trials...
Loading clinical trials...
Cardiovascular and respiratory diseases are the first and third cause of death, respectively. Cardiovascular risk is known to increase in groups with impaired lung function; however, the mechanisms be...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Universidad de Cartagena
Collaborators
NCT07547098 · Cardiovascular Diseases (CVD), Chronic Kidney Disease, and more
NCT07307781 · Chronic Obstructive Pulmonary Disease (COPD)
NCT07383896 · Asthma, COPD
NCT07356310 · Breathing, Lung Function Decreased, and more
NCT07518472 · Pulmonary Disease, Chronic Obstructive (COPD)
Universidad de Cartagena
Cartagena, Departamento de Bolívar
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions